Goldman Sachs Focused Value Fund
Name
As of 04/29/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
8.1%
1 yr return
20.4%
3 Yr Avg Return
8.6%
5 Yr Avg Return
11.9%
Net Assets
$46.5 M
Holdings in Top 10
43.4%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.72%
SALES FEES
Front Load 5.50%
Deferred Load N/A
TRADING FEES
Turnover 78.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
$250
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 04/29/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
GFVAX - Profile
Distributions
- YTD Total Return 8.1%
- 3 Yr Annualized Total Return 8.6%
- 5 Yr Annualized Total Return 11.9%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio 0.51%
- Dividend Yield 1.2%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameGoldman Sachs Focused Value Fund
-
Fund Family NameGoldman Sachs Fund Complex
-
Inception DateJul 31, 2015
-
Shares OutstandingN/A
-
Share ClassA
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerCharles (Brook) Dane
Fund Description
GFVAX - Performance
Return Ranking - Trailing
Period | GFVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 8.1% | -2.2% | 14.6% | 37.43% |
1 Yr | 20.4% | -2.2% | 47.1% | 71.33% |
3 Yr | 8.6%* | -12.4% | 14.3% | 22.20% |
5 Yr | 11.9%* | -9.4% | 106.4% | 64.77% |
10 Yr | N/A* | -0.1% | 20.6% | N/A |
* Annualized
Return Ranking - Calendar
Period | GFVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 13.1% | -42.6% | 47.4% | 73.92% |
2022 | -15.2% | -56.3% | -4.2% | 10.75% |
2021 | 16.9% | -27.2% | 53.7% | 49.31% |
2020 | 7.7% | -36.2% | 2181.7% | 74.47% |
2019 | 26.8% | -22.7% | 40.4% | 29.16% |
Total Return Ranking - Trailing
Period | GFVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 8.1% | -2.2% | 14.6% | 37.43% |
1 Yr | 20.4% | -2.2% | 47.1% | 71.33% |
3 Yr | 8.6%* | -12.4% | 14.3% | 22.20% |
5 Yr | 11.9%* | -9.4% | 106.4% | 64.77% |
10 Yr | N/A* | -0.1% | 20.6% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | GFVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 14.7% | -5.0% | 47.4% | 88.56% |
2022 | -6.6% | -36.8% | -2.2% | 3.05% |
2021 | 24.6% | 3.0% | 124.3% | 72.73% |
2020 | 9.6% | -15.8% | 2266.0% | 89.57% |
2019 | 28.5% | -0.4% | 241.3% | 65.24% |
NAV & Total Return History
GFVAX - Holdings
Concentration Analysis
GFVAX | Category Low | Category High | GFVAX % Rank | |
---|---|---|---|---|
Net Assets | 46.5 M | 2.34 M | 1.55 T | 92.77% |
Number of Holdings | 30 | 1 | 4048 | 94.34% |
Net Assets in Top 10 | 21.7 M | 885 K | 387 B | 91.19% |
Weighting of Top 10 | 43.38% | 0.3% | 112.0% | 16.65% |
Top 10 Holdings
- Exxon Mobil Corp 5.41%
- Danaher Corp 4.98%
- Salesforce Inc 4.65%
- Colgate-Palmolive Co 4.50%
- Marvell Technology Inc 4.15%
- Bank of America Corp 4.11%
- Bristol-Myers Squibb Co 4.01%
- Zimmer Biomet Holdings Inc 3.90%
- Ameren Corp 3.89%
- Lowe's Cos Inc 3.79%
Asset Allocation
Weighting | Return Low | Return High | GFVAX % Rank | |
---|---|---|---|---|
Stocks | 98.50% | 0.00% | 124.03% | 61.56% |
Cash | 1.50% | 0.00% | 99.06% | 39.70% |
Preferred Stocks | 0.00% | 0.00% | 2.38% | 63.68% |
Other | 0.00% | -13.91% | 100.00% | 77.20% |
Convertible Bonds | 0.00% | 0.00% | 5.54% | 61.75% |
Bonds | 0.00% | -0.50% | 93.78% | 63.92% |
Stock Sector Breakdown
Weighting | Return Low | Return High | GFVAX % Rank | |
---|---|---|---|---|
Financial Services | 17.92% | 0.00% | 55.59% | 13.20% |
Healthcare | 16.63% | 0.00% | 60.70% | 17.52% |
Industrials | 13.87% | 0.00% | 29.90% | 11.28% |
Technology | 13.31% | 0.00% | 48.94% | 92.88% |
Consumer Defense | 12.54% | 0.00% | 47.71% | 5.60% |
Utilities | 6.36% | 0.00% | 20.91% | 4.80% |
Energy | 6.12% | 0.00% | 41.64% | 14.56% |
Consumer Cyclical | 4.51% | 0.00% | 30.33% | 94.96% |
Basic Materials | 3.79% | 0.00% | 25.70% | 22.88% |
Communication Services | 2.70% | 0.00% | 27.94% | 92.80% |
Real Estate | 2.25% | 0.00% | 31.91% | 64.16% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | GFVAX % Rank | |
---|---|---|---|---|
US | 98.50% | 0.00% | 124.03% | 48.03% |
Non US | 0.00% | 0.00% | 62.81% | 68.87% |
GFVAX - Expenses
Operational Fees
GFVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 1.72% | 0.01% | 16.07% | 10.52% |
Management Fee | 0.69% | 0.00% | 1.90% | 79.46% |
12b-1 Fee | 0.25% | 0.00% | 1.00% | 49.06% |
Administrative Fee | N/A | 0.00% | 0.85% | N/A |
Sales Fees
GFVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | 5.50% | 1.00% | 5.75% | 57.24% |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
GFVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 0.25% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
GFVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 78.00% | 0.00% | 496.00% | 87.50% |
GFVAX - Distributions
Dividend Yield Analysis
GFVAX | Category Low | Category High | GFVAX % Rank | |
---|---|---|---|---|
Dividend Yield | 1.16% | 0.00% | 25.59% | 48.46% |
Dividend Distribution Analysis
GFVAX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annual | Annual | Quarterly | Quarterly |
Net Income Ratio Analysis
GFVAX | Category Low | Category High | GFVAX % Rank | |
---|---|---|---|---|
Net Income Ratio | 0.51% | -54.00% | 6.06% | 61.40% |
Capital Gain Distribution Analysis
GFVAX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Dec 19, 2023 | $0.176 | OrdinaryDividend |
Dec 14, 2023 | $0.027 | OrdinaryDividend |
Dec 19, 2022 | $0.127 | OrdinaryDividend |
Dec 17, 2021 | $0.074 | OrdinaryDividend |
Dec 17, 2020 | $0.082 | OrdinaryDividend |
Dec 19, 2019 | $0.036 | OrdinaryDividend |
Dec 13, 2019 | $0.115 | OrdinaryDividend |
Dec 20, 2018 | $0.052 | OrdinaryDividend |
Dec 21, 2017 | $0.082 | OrdinaryDividend |
Dec 21, 2016 | $0.111 | OrdinaryDividend |
Dec 22, 2015 | $0.032 | OrdinaryDividend |
GFVAX - Fund Manager Analysis
Managers
Charles (Brook) Dane
Start Date
Tenure
Tenure Rank
Jul 17, 2018
3.87
3.9%
Charles (Brook) Dane is a portfolio manager on the US Equity Team of Goldman Sachs Asset Management, L.P. He joined the Goldman Sachs Asset Management, L.P. in 2010 as a portfolio manager for the Value Team. Before joining the firm, Mr. Dane was a Senior Vice President at Putnam Investments. He spent 13 years at Putnam Investments as a research analyst and more recently as a portfolio manager there. Prior to that, he was an Associate at Dane, Falb, Stone & Co.
Kevin Martens
Start Date
Tenure
Tenure Rank
Dec 27, 2019
2.43
2.4%
Kevin Martens is a portfolio manager on the Goldman Sachs Asset Management, L.P. US Equity ESG Strategy, as well as a portfolio manager on the US Equity Team where he has broad research responsibilities for the Industrials sector across the US Large- and Mid-Cap Equity strategies. Before joining the Investment Adviser in 2015, Mr. Martens spent four years at ClearBridge Investments.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.04 | 39.02 | 7.24 | 2.42 |